Engineered nasal dry powder for the encapsulation of bioactive compounds.

[1]  Cunchuan Zheng,et al.  Understanding the mechanism of the CO2 responsive viscoelastic fluids obtained from cetyltrimethylammonium bromide, sodium salicylate and N, N-dimethylcyclohexylamine , 2021 .

[2]  C. Feldmann,et al.  Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals , 2021, Drug delivery and translational research.

[3]  R. Vehring,et al.  Leucine Enhances the Dispersibility of Trehalose-Containing Spray-Dried Powders on Exposure to a High-Humidity Environment. , 2021, International journal of pharmaceutics.

[4]  S. K. Ayop,et al.  Temperature and Concentration Dependent Viscosity of Microcrystalline Cellulose in Water , 2021, Journal of Advanced Research in Fluid Mechanics and Thermal Sciences.

[5]  M. Sztucki,et al.  Mannitol Crystallization at Sub-Zero Temperatures: Time/Temperature-Resolved Synchrotron X-ray Diffraction Study and the Phase Diagram. , 2021, The journal of physical chemistry letters.

[6]  O. Merkel,et al.  Intranasal drug delivery: opportunities and toxicologic challenges during drug development , 2021, Drug Delivery and Translational Research.

[7]  A. Goyal,et al.  Recent Advancement in Nanotechnology-Based Drug Delivery System Against Viral Infections , 2021, AAPS PharmSciTech.

[8]  Lalduhsanga Pachuau,et al.  Encapsulation of Bioactive Compound and Its Therapeutic Potential , 2020, Advanced Structured Materials.

[9]  S. Lebeer,et al.  Probiotic nasal spray development by spray drying. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  L. Grover,et al.  Formulation of a composite nasal spray enabling enhanced surface coverage and prophylaxis of SARS-COV-2 , 2020, bioRxiv.

[11]  M. Citardi,et al.  Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework , 2020, Journal of Otolaryngology - Head & Neck Surgery.

[12]  P. Young,et al.  Nasal Powder Formulation of Tranexamic Acid and Hyaluronic Acid for the Treatment of Epistaxis , 2020, Pharmaceutical Research.

[13]  B. E. Benediktsdóttir.  Chitosan and Trimethyl Chitosan (TMC) as Drug Absorption Enhancers , 2020 .

[14]  É. C. A. Gonçalves,et al.  Spray-drying wall materials: relationship with bioactive compounds , 2020, Critical reviews in food science and nutrition.

[15]  O. B. Ozdoganlar,et al.  Analysis of In Vitro Cytotoxicity of Carbohydrate-Based Materials Used for Dissolvable Microneedle Arrays , 2020, Pharmaceutical Research.

[16]  I. Gitlin,et al.  The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  K. Wasilewska,et al.  Ethylcellulose–A Pharmaceutical Excipient with Multidirectional Application in Drug Dosage Forms Development , 2019, Materials.

[18]  J. Moses,et al.  Spray freeze drying: Emerging applications in drug delivery. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Gabriela G Pereira,et al.  Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery , 2019, Pharmaceutics.

[20]  Hui Shao,et al.  Facile and green preparation of hemicellulose-based film with elevated hydrophobicity via cross-linking with citric acid , 2019, RSC advances.

[21]  S. Lokhande.  A Review on Intranasal Drug Delivery System with Recent Advancement , 2018 .

[22]  H. Kho,et al.  Effects of molecular weight of hyaluronic acid on its viscosity and enzymatic activities of lysozyme and peroxidase. , 2018, Archives of oral biology.

[23]  Qing-da An,et al.  Preparation and properties of a thin membrane based on sodium alginate grafting acrylonitrile , 2017 .

[24]  M. Bercea,et al.  Hyaluronic acid gels with tunable properties by conjugating with a synthetic copolymer , 2017 .

[25]  Todor A Popov,et al.  Methyl-cellulose powder for prevention and management of nasal symptoms , 2017, Expert review of respiratory medicine.

[26]  A. Monteiro-Moreira,et al.  Physicochemical Properties of Edible Seed Hemicelluloses , 2017 .

[27]  J. Talton,et al.  Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder , 2017, PloS one.

[28]  F. Sonvico,et al.  Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery , 2017, Drug development and industrial pharmacy.

[29]  R. Vehring,et al.  Analysis of cohesion forces between monodisperse microparticles with rough surfaces , 2016 .

[30]  R. Vehring,et al.  Control of the radial distribution of chemical components in spray-dried crystalline microparticles , 2016 .

[31]  M. Woo,et al.  In situ observation on particle formation process via single droplet drying apparatus: Effects of precursor composition on particle morphology , 2016 .

[32]  R. Scherließ,et al.  Carrier-based dry powder formulation for nasal delivery of vaccines utilizing BSA as model drug , 2016 .

[33]  R. Ambrus,et al.  Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells , 2016, Molecules.

[34]  J. Reid,et al.  Effect of crystallization kinetics on the properties of spray dried microparticles , 2016 .

[35]  F. Sonvico,et al.  Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation , 2016, Drug development and industrial pharmacy.

[36]  Gwangseong Kim,et al.  Feasibility Investigation of Cellulose Polymers for Mucoadhesive Nasal Drug Delivery Applications. , 2015, Molecular pharmaceutics.

[37]  Gulzar Ahmad Nayik,et al.  Stickiness Problem Associated with Spray Drying of Sugar and Acid Rich Foods: A Mini Review , 2015 .

[38]  D. Nobes,et al.  Analysis of the Particle Formation Process of Structured Microparticles. , 2015, Molecular pharmaceutics.

[39]  Z. Lalchev,et al.  Effect of hydrophilic polymers on the wettability, static and dynamic, of solid substrate covered by confluent monolayer of air-damaged SIRC cells , 2015, Biotechnology, biotechnological equipment.

[40]  P. Kraisit,et al.  Effect of Various Types of Hydroxypropyl Methylcellulose (HPMC) Films on Surface Free Energy and Contact Angle , 2014 .

[41]  K. Abnous,et al.  Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants. , 2014, International journal of pharmaceutics.

[42]  Dino Di Carlo,et al.  Metallization and Biopatterning on Ultra-Flexible Substrates via Dextran Sacrificial Layers , 2014, PloS one.

[43]  Lee A. Walsh,et al.  Spin coating of hydrophilic polymeric films for enhanced centrifugal flow control by serial siphoning , 2014 .

[44]  L. Gradon,et al.  Formation of particles for dry powder inhalers , 2014 .

[45]  M. Boraey,et al.  Diffusion controlled formation of microparticles , 2014 .

[46]  W. Hinrichs,et al.  Unraveling protein stabilization mechanisms: vitrification and water replacement in a glass transition temperature controlled system. , 2013, Biochimica et biophysica acta.

[47]  Danforth P Miller,et al.  Improvement of the dispersibility of spray-dried budesonide powders using leucine in an ethanol–water cosolvent system , 2013 .

[48]  Shirui Mao,et al.  A novel permeation enhancer: N-succinyl chitosan on the intranasal absorption of isosorbide dinitrate in rats. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[49]  J. Suman.  Current understanding of nasal morphology and physiology as a drug delivery target , 2013, Drug Delivery and Translational Research.

[50]  Per Gisle Djupesland,et al.  Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review , 2012, Drug Delivery and Translational Research.

[51]  C. Ramírez,et al.  Study of contact angle, wettability and water vapor permeability in carboxymethylcellulose (CMC) based film with murta leaves (Ugni molinae Turcz) extract , 2012 .

[52]  N. Urbanetz,et al.  Spray Drying of Mannitol as a Drug Carrier—The Impact of Process Parameters on Product Properties , 2012 .

[53]  K. Senthilkumar,et al.  Nasal Drug Delivery System - An Overview , 2012 .

[54]  W. Hennink,et al.  Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[55]  Xiaojiang Li,et al.  Physicochemical Characterization and Water Vapor Sorption of Organic Solution Advanced Spray-Dried Inhalable Trehalose Microparticles and Nanoparticles for Targeted Dry Powder Pulmonary Inhalation Delivery , 2011, AAPS PharmSciTech.

[56]  Wouter L J Hinrichs,et al.  Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization. , 2011, Vaccine.

[57]  R. Ho,et al.  Effects of Localized Hydrophilic Mannitol and Hydrophobic Nelfinavir Administration Targeted to Olfactory Epithelium on Brain Distribution , 2011, AAPS PharmSciTech.

[58]  R. Keshari.  Advances in nasal trans-mucosal drug delivery , 2011 .

[59]  C. Meier,et al.  Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold , 2010, Respiratory research.

[60]  Brian Pulliam,et al.  Immunization of Guinea Pigs with Novel Hepatitis B Antigen as Nanoparticle Aggregate Powders Administered by the Pulmonary Route , 2010, The AAPS Journal.

[61]  R. Suryanarayanan,et al.  Trehalose Crystallization During Freeze-Drying: Implications On Lyoprotection , 2010 .

[62]  K. Sawant,et al.  Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery , 2009, Journal of microencapsulation.

[63]  C. Deroanne,et al.  Effect of water uptake on amorphous inulin properties. , 2009 .

[64]  J. Remon,et al.  Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine. , 2009, Vaccine.

[65]  S. Palzer.  Influence of material properties on the agglomeration of water-soluble amorphous particles , 2009 .

[66]  J. Mano,et al.  hitosan derivatives obtained by chemical modifications for biomedical nd environmental applications , 2022 .

[67]  A. Bajpai,et al.  Removal of Toxic As (V) Ions by Adsorption onto Alginate and Carboxymethyl Cellulose Beads , 2008 .

[68]  Paul Jelen,et al.  Lactose: Crystallization, hydrolysis and value-added derivatives , 2008 .

[69]  W. Hinrichs,et al.  Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities , 2008, Pharmaceutical Research.

[70]  Vincent J. Sullivan,et al.  Formulation of a dry powder influenza vaccine for nasal delivery , 2006, AAPS PharmSciTech.

[71]  Reinhard Vehring,et al.  Pharmaceutical Particle Engineering via Spray Drying , 2007, Pharmaceutical Research.

[72]  W. Fokkens,et al.  The 'best method' of topical nasal drug delivery: comparison of seven techniques. , 2006, Rhinology.

[73]  A. Bernkop‐Schnürch,et al.  Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. , 2006, International journal of pharmaceutics.

[74]  Steven J. Shire,et al.  Protein Inhalation Powders: Spray Drying vs Spray Freeze Drying , 1999, Pharmaceutical Research.

[75]  J. Ong,et al.  Contact angle, protein adsorption and osteoblast precursor cell attachment to chitosan coatings bonded to titanium , 2003, Journal of biomaterials science. Polymer edition.

[76]  S. Garg,et al.  Permeability issues in nasal drug delivery. , 2002, Drug discovery today.

[77]  H. Nawata,et al.  Nasal glucagon delivery using microcrystalline cellulose in healthy volunteers. , 2002, International journal of pharmaceutics.

[78]  Y. Tabata,et al.  Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats , 2002, The Journal of pharmacy and pharmacology.

[79]  J. Remon,et al.  Toxicological evaluation of a bioadhesive nasal powder containing a starch and Carbopol 974 P on rabbit nasal mucosa and slug mucosa. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[80]  H. Natsume,et al.  Effect of poly-L-arginine on the nasal absorption of FITC-dextran of different molecular weights and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats. , 2001, International journal of pharmaceutics.

[81]  D. V. Boger,et al.  Rheology of dextran solutions , 2001 .

[82]  R. Sciot,et al.  Toxicological investigations of the effects carboxymethylcellulose on ciliary beat frequency of human nasal epithelial cells in primary suspension culture and in vivo on rabbit nasal mucosa. , 2000, International journal of pharmaceutics.

[83]  N Verbeke,et al.  Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems. , 2000, International journal of pharmaceutics.

[84]  P. Luner,et al.  Surface free energy of ethylcellulose films and the influence of plasticizers. , 1999, International journal of pharmaceutics.

[85]  M. Zenkel,et al.  Filtration of Particulates in the Human Nose , 1998, The Laryngoscope.

[86]  T. Randolph,et al.  Phase separation of excipients during lyophilization: effects on protein stability. , 1997, Journal of pharmaceutical sciences.

[87]  Leming,et al.  Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections , 1997 .

[88]  W Wang,et al.  Viscosity and flow properties of concentrated solutions of chitosan with different degrees of deacetylation. , 1994, International journal of biological macromolecules.

[89]  M. M. Mozell,et al.  Velocity profiles measured for airflow through a large-scale model of the human nasal cavity. , 1993, Journal of applied physiology.

[90]  T. Sukamoto,et al.  Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine. , 1991, Japanese journal of pharmacology.

[91]  1: Final Report on the Safety Assessment of Hydroxyethylcellulose, Hydroxypropylcellulose, Methylcellulose, Hydroxypropyl Methylcellulose, and Cellulose Gum , 1986 .

[92]  P. Howard,et al.  Solution properties of cellulose triacetate. II. Solubility and viscosity studies , 1968 .